StonvexLoading…
StonvexStonvexStonvexCore line items from GELS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2023 2023-06-30 |
|---|---|---|
Revenue | A$165.65K | A$79.84K |
Operating Income | A$-5.50M | A$-3.10M |
Net Income | A$-6.65M | A$-3.51M |
EPS (Diluted) | A$-0.72 | A$-0.44 |
Total Assets | A$21.48M | A$22.49M |
Total Liabilities | A$5.67M | A$3.84M |
Cash & Equivalents | A$344.65K | A$399.22K |
Free Cash Flow OCF − CapEx | A$-5.52M | A$-1.80M |
Shares Outstanding | Not available | Not available |